# Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood

> **NCT02509767** · PHASE4 · COMPLETED · sponsor: **Planned Parenthood Federation of America** · enrollment: 401 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Subcutaneous depot medroxyprogesterone acetate

## Key facts

- **NCT ID:** NCT02509767
- **Lead sponsor:** Planned Parenthood Federation of America
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2017-04
- **Final completion:** 2017-12
- **Target enrollment:** 401 (ACTUAL)
- **Last updated:** 2019-09-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02509767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02509767, "Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02509767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*